Stock I25 IRHYTHM TECHNOLOGIES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus iRhythm Technologies, Inc. Deutsche Boerse AG

Equities

I25

US4500561067

Real-time Estimate Tradegate
Other stock markets
 18:04:41 26/06/2024 BST 		5-day change 1st Jan Change
96.25 EUR +2.39% Intraday chart for iRhythm Technologies, Inc. +3.85% -3.08%
06-20 IRhythm Technologies Shares Rise After Upgrade From Wolfe Research MT
06-20 Wolfe Research Upgrades iRhythm Technologies to Outperform From Peer Perform, Price Target is $115 MT

Evolution of the average Target Price on iRhythm Technologies, Inc.

Price target over the last 5 years

History of analyst recommendation changes

51545e71965646bfa590369d95f89.nLb3x012XzmEWRqlVdYtRJhJIQ77szl4jiR8eOQ005g.6uHAqScmEU22M3HAN4B7dN17VXyI1kw3wEY3SNRupPnK1aCtJyMJS8wqeQ~7606e04195259be15d36c12a2eba41b3

Analyst Recommendations on iRhythm Technologies, Inc.

IRhythm Technologies Shares Rise After Upgrade From Wolfe Research MT
Wolfe Research Upgrades iRhythm Technologies to Outperform From Peer Perform, Price Target is $115 MT
Needham Adjusts iRhythm Technologies' PT to $138 From $137, Says 'Strong' Q1 Revenue Growth Should Continue; Keeps Buy Rating MT
Needham Adjusts iRhythm Technologies' Price Target to $137 From $136, Keeps Buy Rating MT
Needham Raises iRhythm Technologies' Price Target to $136 From $108, Keeps Buy Rating MT
Truist Securities Adjusts iRhythm Technologies Price Target to $115 From $100, Maintains Buy Rating MT
Citigroup Upgrades iRhythm Technologies to Buy From Neutral, Raises Price Target to $110 From $85 MT
Morgan Stanley Adjusts Price Target on iRhythm Technologies to $135 From $149, Maintains Overweight Rating MT
Canaccord Genuity Adjusts Price Target on iRhythm Technologies to $116 From $136, Maintains Buy Rating MT
Truist Adjusts iRhythm Technologies' Price Target to $138 From $155, Keeps Buy Rating MT
Oppenheimer Adjusts iRhythm Technologies Price Target to $165 From $125, Maintains Outperform Rating MT
Needham Adjusts Price Target on iRhythm Technologies to $130 From $151, Keeps Buy Rating MT
BTIG Adjusts iRhythm Technologies' Price Target to $140 From $165, Keeps Buy Rating MT
Citigroup Adjusts Price Target on iRhythm Technologies to $115 From $135, Maintains Neutral Rating MT
Oppenheimer Adjusts iRhythm Technologies Price Target to $125 From $166, Maintains Outperform Rating MT
Truist Securities Adjusts Price Target on iRhythm Technologies to $155 From $154, Maintains Buy Rating MT
Citigroup Adjusts Price Target on iRhythm Technologies to $135 From $130, Maintains Neutral Rating MT
Needham Raises Price Target on iRhythm Technologies to $151 From $133, Maintains Buy Rating MT
BTIG Adjusts iRhythm Technologies' Price Target to $170 From $168, Keeps Buy Rating MT
Truist Securities Adjusts Price Target on iRhythm Technologies to $154 From $137, Keeps Buy Rating MT
Citigroup Adjusts iRhythm Technologies Price Target to $130 From $110, Maintains Neutral Rating MT
Canaccord Genuity Adjusts iRhythm Technologies' Price Target to $143 From $135, Keeps Buy Rating MT
Morgan Stanley Adjusts Price Target on iRhythm Technologies to $130 From $128, Maintains Overweight Rating MT
Needham Adjusts Price Target on iRhythm Technologies to $133 From $140, Maintains Buy Rating MT
Wells Fargo Initiates iRhythm Technologies at Overweight Rating With $150 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
101.7 USD
Average target price
135.5 USD
Spread / Average Target
+33.24%
High Price Target
165 USD
Spread / Highest target
+62.31%
Low Price Target
115 USD
Spread / Lowest Target
+13.12%

Consensus detail

Consensus revision (last 18 months)

Analysts covering iRhythm Technologies, Inc.

Wolfe Research
Needham & Co.
Truist Securities
Citigroup
Morgan Stanley
Canaccord Genuity
Oppenheimer
BTIG
Wells Fargo Securities
JPMorgan Chase
J.P. Morgan Chase
Baird
Colliers Securities

Ratings for iRhythm Technologies, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. IRTC Stock
  4. I25 Stock
  5. Consensus iRhythm Technologies, Inc.